<DOC>
	<DOCNO>NCT00949494</DOCNO>
	<brief_summary>Hylan G-F 20 ( Synvisc ) FDA-approved hyaluronate derivative use treat knee osteoarthritis ( OA ) . Animal study show Synvisc favorable effect cartilage inject joint . This study attempt evaluate effect Synvisc inject knee patient knee OA mean specialized MRI technology ( dGEMRIC ) .</brief_summary>
	<brief_title>Effects Synvisc Cartilage Knee Osteoarthritis ( OA )</brief_title>
	<detailed_description>Hylan G-F 20 ( Synvisc ) FDA-approved hyaluronate derivative administer injection osteoarthritic joint treatment osteoarthritis . Preclinical investigation demonstrate Hylan G-F 20 favorably affect chondrocyte metabolism recent clinical study [ Ann Rheum Dis . 2004 May ; 63 ( 5 ) :478-82 ; Osteoarthritis Cartilage . 2005 Mar ; 13 ( 3 ) :216-24 ] provide support disease-modifying effect Hylan G-F 20 therapy . This study utilize dGEMRIC image patient knee OA ass effect Hylan G-F 20 therapy cartilage vivo time . Delayed Gadolinium Enhanced MRI Cartilage ( dGEMRIC ) permit quantitative assessment GAG distribution within intact cartilage vivo . Since dGEMRIC noninvasive , technique may useful non-invasively monitor influence various treatment hyaline cartilage .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Males females 40 80 year age meet ACR Criteria osteoarthritis knee . 2 . Radiographic evidence OA , Kellgren Lawrence grade I III prior Xrays ( take within 6 month screen visit ) screening . Only tibiofemoral joint evaluate ( patellofemoral disease consider ) . 3 . Mild moderate level knee pain determined VAS pain score 36/10 stable least 1 month prior screen visit . 4 . Stable management regimen knee OA pain least 1 month prior screen visit . Subjects manage physical measure alone , simple analgesic , NSAIDs , nutriceuticals agent significant change treatment regimen 1 month prior screen visit . 5 . Ability comply requirement study 6 . Able maintain stable exercise/activity program course study 6 . Signed dated consent form 7 . Women childbearing potential agree use appropriate method contraception confirm negative pregnancy test screening . 1 . Radiographic evidence Kellgren Lawrence grade IV OA 2 . Knee pain &lt; 3 &gt; 6 10 VAS pain scale . 3 . Change management regimen knee OA precede month . 4 . Subjects metal implant cardiac pacemaker , spinal cord stimulators bionic ear device . 5 . Subjects unable receive gadolinium contrast agent injection contraindication . 6 . Unable undergo MRI exam contraindication , e.g . claustrophobia . 7 . Inflammatory arthritis , e.g . rheumatoid arthritis , psoriatic arthritis , systemic lupus erythematosus . 8 . History disease may involve study joint include inflammatory joint disease , crystalline disease , endocrinopathies , metabolic disease , knee infection choose knee , neuropathic disorder , avascular necrosis , Paget 's disease tumor 9 . Recent trauma study joint . 10 . Known loose body study joint . 11 . Patients take oral steroid . 12 . Patients active malignancy . 13 . Patients either highperformance athlete , opinion investigator , highly sedentary likely ambulate least 2030 minutes/day . 14 . In opinion investigator , subject unstable medical condition . 15 . Participating another study participate study evaluate investigational drug , device biologics within three month enrollment study . 16 . Study subject ever previously receive hyaluronan therapy . 17 . Arthroscopic open surgery study joint within previous twelve month . 18 . Anticipated need knee surgery study joint . 19 . History joint replacement , intraarticular fracture , osteotomy , arthroplasty meniscectomy study knee . 20 . Intraarticular injection corticosteroid study joint within past six month . 21 . Morbid obesity define BMI great 40 . 22 . Study subject know sensitivity component Hylan GF 20 include bird feather , egg poultry . 23 . Subject active systemic infection . 24 . Subject coumadin anticoagulant . 25 . Musculoskeletal pain may preclude subject remain motionless MRI exam . 26 . Women pregnant lactating . 27 . Subjects `` clinically significant '' malalignment .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>knee osteoarthritis , synvisc , hyaluronan , dGEMRIC , cartilage</keyword>
</DOC>